GORE INITIATES THE RELIEF CLINICAL STUDY EVALUATING PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF
CAUTION: Investigational device. Limited by United States law to investigational use.
Nov 1, 2022
CAUTION: Investigational device. Limited by United States law to investigational use.
Nov 1, 2022
CAUTION: Investigational device. Limited by United States law to investigational use.W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior
Oct 28, 2022
Acquisition of graft technology builds upon Gore’s dialysis access solutions
Aug 12, 2022
Approval brings first flexible, off-the-shelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment.
May 13, 2022
CAUTION: Investigational device. Limited by United States law to investigational use.
Apr 12, 2022
After a decade of clinical use* and more than 50,000 devices sold globally, the GORE® CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care.
Jan 19, 2022
The innovative device and delivery system combine proven conformability with new levels of control.
Jan 6, 2021